Crossmark

A biocompatible nanoformulation of curcumin analogue and curd exosomes targeting EphA2 signalling cascade in head and neck cancer

Published Online: 2024-09-18

Published Print: 2024-12

Authors

Pande, Kaumudi

Bettadaiah, B. K.

Kannan, Anbarasu
License Information

Text and Data Mining valid from 2024-09-18

Version of Record valid from 2024-09-18
More Information

Article History

Received: 21 February 2024

Accepted: 14 August 2024

First Online: 18 September 2024

Declarations

:

: Not applicable.

: All the authors agree to the publication of this manuscript.

: The authors declare no competing interests.

Document is current